Skip to Content
Merck
All Photos(1)

Documents

Safety Information

311-GS

Sigma-Aldrich

Smooth Muscle Cell Growth Supplement (30 ml)

Synonym(s):

SMCGS

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
12352207
NACRES:
NA.71

form

liquid

Quality Level

100

shelf life

1 yr

manufacturer/tradename

Cell Applications, Inc

shipped in

dry ice

storage temp.

−20°C

General description

Smooth muscle cell growth supplement is added to the basal medium to create a growth medium. It is enhanced for the characteristics and requirements unique to smooth muscle cells.

Application

Smooth muscle cell growth supplement (30 ml) has been used to grow cultures of human smooth muscle cells (SMCs). It has also been used in SMCS to grow pulmonary arterial hypertension-pulmonary artery (PAH-PA) smooth muscle cells (PASMCs).

Quality

Each lot was tested for the ability to support plating, spreading and proliferation

Preparation Note

contained in protocol

Storage Class Code

10 - Combustible liquids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

PDSCL

Poisonous substance

JAN Code

311-GS:

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Valerie Nadeau et al.
Pulmonary circulation, 8(1), 2045893217741429-2045893217741429 (2017-10-25)
Dysregulated metabolism and rarefaction of the capillary network play a critical role in pulmonary arterial hypertension (PAH) etiology. They are associated with a decrease in perfusion of the lungs, skeletal muscles, and right ventricle (RV). Previous studies suggested that endothelin-1
Jeffrey T Krawiec et al.
Tissue engineering. Part A, 21(3-4), 426-437 (2014-08-15)
Autologous tissue-engineered blood vessels (TEBVs) generated using adult stem cells have shown promising results, but many preclinical evaluations do not test the efficacy of stem cells from patient populations likely to need therapy (i.e., elderly and diabetic humans). Two critical

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service